Hydroxyzine is a generic drug that’s prescribed for anxiety and other conditions in adults and children. Hydroxyzine comes as an oral tablet that’s typically taken up to four times per day ...

CANONSBURG, Pa. (AP) — CANONSBURG, Pa. (AP) — Viatris Inc (VTRS) on Thursday reported third-quarter net income of $94.8 million. On a per-share basis, the Canonsburg, Pennsylvania-based ...

Viatris (VTRS) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.68 per share. This compares to earnings of $0.78 per share a year ago. These figures ...

Novartis and Viatris have become the latest pharma companies to be named in lawsuits claiming that they profited from the unlawful use of HeLa cells derived from cells taken from a cancer patient ...

Investors cheered Viatris' Q3 2024 earnings release Thursday, bidding the stock up +13.5%. Generic pharmaceuticals have performed well and Viatris is a top idea in the space that should flourish ...

Viatris has made a play to expand its branded medicines business by licensing two late-stage drugs from Idorsia – for acute myocardial infarction (AMI) and systemic lupus erythematosus (SLE ...

Despite operational successes, Viatris faced a significant 71% drop in GAAP net earnings due to international market pressures. Viatris delivered a mixed quarter, topping earnings expectations but ...

(RTTNews) - Viatris Inc. (VTRS) released a profit for third quarter that decreased from the same period last year but beat the Street estimates. The company's earnings came in at $94.8 million ...

Such forward looking statements may include statements that Viatris' Board of Directors declared a quarterly dividend of $0.12 per share for each issued and outstanding share of the Company's ...